Adamas Pharmaceuticals Inc: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2020)
- $74.5M
- Net Income/Loss (FY2020)
- -$57.4M
- Total Assets (FY2020)
- $120.0M
- Total Equity (FY2020)
- -$50.0M
- Cash Flows from Operating Activities (FY2020)
- -$50.7M
Source: Adamas Pharmaceuticals Inc 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
